JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:354-358; doi:10.1136/jnnp.2005.075119
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorson, K C
Right arrow Articles by Ropper, A H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorson, K C
Right arrow Articles by Ropper, A H

PAPER

Additional causes for distal sensory polyneuropathy in diabetic patients

K C Gorson, A H Ropper

Department of Neurology, St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA, USA

Correspondence to:
Correspondence to:
Dr Kenneth C Gorson
Department of Neurology, St. Elizabeth’s Medical Center, 736 Cambridge Street, Boston, MA 02135, USA; kengorson{at}comcast.net

Objective: To assess the frequency of additional causes of distal sensory polyneuropathy (DSP) in patients with diabetes mellitus (DM).

Methods: Retrospective review of patients with DM and DSP during a 5 year period. A quantitative sensory score (QSS) was determined at the initial evaluation and extensive laboratory and EMG studies were performed. Patients with one or more potential causes for DSP were compared to those with DM alone.

Results: Fifty five patients (53%) had potential additional causes for DSP. These included: neurotoxic medications (seven), alcohol abuse (six), and B12 deficiency and renal disease (four each). The most common laboratory abnormalities were: abnormally low levels of vitamin B6 (11) or B1 (10), monoclonal gammopathy (eight), and hypertriglyceridaemia (eight). Twenty six (25%) subjects had more than one additional cause. Nine (9%) had three or more demyelinating features on EMG. There was a trend toward a lower QSS score (p = 0.05) and reduced mean amplitude of the sensory potentials in those with additional causes. Those with additional causes more often had upper limb sensory symptoms (p = 0.001) and sensory findings (p = 0.003).

Conclusion: There was a high frequency of additional sources of DSP in patients with DM. These patients more often had sensory symptoms and findings in the hands. Tests that may be useful in the evaluation of DSP in diabetic patients include measures of vitamins B1, B6, B12, serum triglycerides, and immunofixation.


Keywords: diabetes; diabetic neuropathy; distal sensory neuropathy; polyneuropathy




eLetters:

Read all eLetters

Additional causes for distal sensory polyneuropathy in diabetic patients?
Marinus Vermeulen, et al.
JNNP Online, 26 Jun 2006 [Full text]
Diabetes with neuropathy - implicated for wrong reasons??
Thomas Chemmanam
JNNP Online, 2 Oct 2006 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.